Skip to content

Evaluation of the effectiveness of botulinum toxin in preventing hypertrophic scarring

Evaluation of the effectiveness of botulinum toxin in preventing hypertrophic scarring at the site of surgical wounds on the trunk, limbs and neck

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100314003566N15
Enrollment
30
Registered
2024-07-17
Start date
2024-07-22
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scar. Hypertrophic scar

Interventions

Intervention 1: Intervention group: First intervention: Botulinum toxin A (BTA) of Diston brand with a concentration of 0.1 ml of BTA will be injected at a site 1 cm away from the edges of the wound (

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients between 18 and 80 years of age with recent history of trunk, neck or extremity surgery in less than 10 days Insensitivity to botulinum toxin Consent to participate in the research project Scar site with at least 2 cm

Exclusion criteria

Exclusion criteria: History of allergy to botulinum toxin Pregnancy or breastfeeding Recent botulinum injection within 6 months History of radiotherapy and chemotherapy History of wound healing disorder History of recent surgery at the current site of surgery Drug abuse Any other cosmetic procedure at the surgical site, including laser or filler injection Myasthenia gravis and other neuromuscular disorders

Design outcomes

Primary

MeasureTime frame
Side effects. Timepoint: Before the intervention, 3 months after the intervention, 6 months after the intervention. Method of measurement: Clinical examinations.;Scar evaluation. Timepoint: Before the intervention, 3 months after the intervention, 6 months after the intervention. Method of measurement: Stony Brook Scar Evaluation Scales.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamide Azimi

Tabriz University of Medical Sciences

azimi@tbzmed.ac.ir+98 41 1540 6612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026